Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Additions to Study Design

<< Previous

Bullboard Posts

Next >>

Comment by judgesmailson Mar 22, 2024 8:37pm

234 Views

Post# 35948387

RE:RE:RE:RE:RE:RE:RE:Additions to Study Design

Interesting perspective and I agree to some extent.
I think the company is continually trying to succeed, but without a doubt they have dropped the ball at times. Mostly a victim of 'the system' (& all the covid bullsh--), but some of the blame is on Theralase leadership also.

Pre BDT is supposed to be in the rear view mirror. But not a peep about that. Should be at least a couple of new people in the trials now too. But not a peep about that either.

Would sure be nice to know where things stand.

Long (over 10 years) and still optimistic that his will eventually blossom.

-Judgesmails

<< Previous

Bullboard Posts

Next >>

A junior copper-gold stock trading at a bargain of monumental proportions